Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biofrontera (BFRI) Other Non Operating Income (2020 - 2025)

Biofrontera has reported Other Non Operating Income over the past 6 years, most recently at $373000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 179.36% year-over-year to $373000.0; the TTM value through Dec 2025 reached $40000.0, up 104.93%, while the annual FY2025 figure was $40000.0, 112.66% up from the prior year.
  • Other Non Operating Income for Q4 2025 was $373000.0 at Biofrontera, up from $30000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $373000.0 in Q4 2025 and troughed at -$470000.0 in Q4 2024.
  • A 5-year average of -$6300.0 and a median of $14500.0 in 2022 define the central range for Other Non Operating Income.
  • On a YoY basis, Other Non Operating Income climbed as much as 259.09% in 2023 and fell as far as 4766.67% in 2023.
  • Year by year, Other Non Operating Income stood at $270000.0 in 2021, then crashed by 98.89% to $3000.0 in 2022, then tumbled by 4766.67% to -$140000.0 in 2023, then tumbled by 235.71% to -$470000.0 in 2024, then skyrocketed by 179.36% to $373000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for BFRI at $373000.0 in Q4 2025, $30000.0 in Q3 2025, and -$264000.0 in Q2 2025.